共 215 条
[11]
Mouridsen K(2013)Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke JAMA Neurol. 70 353-8
[12]
Ostergaard L(2013)A safe and easy introduction of darbepoetin-alpha in patients receiving maintenance hemodialysis and epoetin monotherapy: A “half-and-half” combination therapy Curr Ther Res Clin Exp. 74 5-63
[13]
Pan Y(2014)Regulation of Hepcidin-25 by short- and long-acting rhEPO may be dependent on ferritin and predict the response to rhEPO in hemodialysis patients Nephron Extra. 4 55-4806
[14]
Wang A(2003)Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling Proc Natl Acad Sci U S A. 100 4802-184
[15]
Liu G(2006)Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs J Am Coll Cardiol. 48 176-1926
[16]
Zhao X(2009)Erythropoietin in patients with acute coronary syndrome and its cardioprotective action after percutaneous coronary intervention Circ J. 73 1920-5769
[17]
Meng X(2008)Hypoxic preconditioning protects rat hearts against ischaemia–reperfusion injury: role of erythropoietin on progenitor cell mobilization J Physiol. 586 5757-479
[18]
Zhao K(2004)Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion J Cardiovasc Pharmacol. 44 473-291
[19]
Wang Y(2004)Erythropoietin in cardiovascular diseases Eur Heart J. 25 285-e656
[20]
Zhao X(2009)Recombinant human erythropoietin in the treatment of acute ischemic stroke Stroke. 40 e647-138